Global Ultrasonic Microbubble Contrast Agents Market Growth 2026-2032

June 2026 | 135 pages | ID: G0677239E232EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Ultrasonic Microbubble Contrast Agents market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Ultrasound microbubble contrast agents are primarily composed of tiny bubbles that reflect sound waves under the influence of ultrasound, thereby enhancing the contrast and clarity of ultrasound images. These agents are widely used in ultrasound examinations of the heart, liver, and other organs.

United States market for Ultrasonic Microbubble Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Ultrasonic Microbubble Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Ultrasonic Microbubble Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Ultrasonic Microbubble Contrast Agents players cover GE Healthcare, Bracco, Lantheus Medical Imaging, Miltenyi Biotec, NanoPET Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Ultrasonic Microbubble Contrast Agents Industry Forecast? looks at past sales and reviews total world Ultrasonic Microbubble Contrast Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Ultrasonic Microbubble Contrast Agents sales for 2026 through 2032. With Ultrasonic Microbubble Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ultrasonic Microbubble Contrast Agents industry.

This Insight Report provides a comprehensive analysis of the global Ultrasonic Microbubble Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ultrasonic Microbubble Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ultrasonic Microbubble Contrast Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ultrasonic Microbubble Contrast Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ultrasonic Microbubble Contrast Agents.

This report presents a comprehensive overview, market shares, and growth opportunities of Ultrasonic Microbubble Contrast Agents market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Albumin-based Envelope
  • Liposome Envelope
  • Multimer-based Envelope
  • Others
Segmentation by Application:
  • Liver Ultrasonography
  • Angiographic Ultrasonography
  • Cardiac Ultrasonography
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • GE Healthcare
  • Bracco
  • Lantheus Medical Imaging
  • Miltenyi Biotec
  • NanoPET Pharma
  • ImaRx Therapeutics
  • Microvascular Therapeutics
  • POINTbiomedical
  • Bayer
  • Qi-hui Biopharmaceutical
  • Runkun Pharmaceutical
  • Feiruida Medical
  • Lizhuo Pharmaceutical
  • Fuman Group
  • SUN? Med-Engineering
  • Starleaf
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ultrasonic Microbubble Contrast Agents market?
What factors are driving Ultrasonic Microbubble Contrast Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ultrasonic Microbubble Contrast Agents market opportunities vary by end market size?
How does Ultrasonic Microbubble Contrast Agents break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Ultrasonic Microbubble Contrast Agents Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Ultrasonic Microbubble Contrast Agents by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Ultrasonic Microbubble Contrast Agents by Country/Region, 2021, 2025 & 2032
2.2 Ultrasonic Microbubble Contrast Agents Segment by Type
  2.2.1 Albumin-based Envelope
  2.2.2 Liposome Envelope
  2.2.3 Multimer-based Envelope
  2.2.4 Others
  2.2.5 Ultrasonic Microbubble Contrast Agents Sales by Type
    2.2.5.1 Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2026)
    2.2.5.2 Global Ultrasonic Microbubble Contrast Agents Revenue and Market Share by Type (2021-2026)
    2.2.5.3 Global Ultrasonic Microbubble Contrast Agents Sale Price by Type (2021-2026)
2.3 Ultrasonic Microbubble Contrast Agents Segment by Application
  2.3.1 Liver Ultrasonography
  2.3.2 Angiographic Ultrasonography
  2.3.3 Cardiac Ultrasonography
  2.3.4 Others
  2.3.5 Ultrasonic Microbubble Contrast Agents Sales by Application
    2.3.5.1 Global Ultrasonic Microbubble Contrast Agents Sale Market Share by Application (2021-2026)
    2.3.5.2 Global Ultrasonic Microbubble Contrast Agents Revenue and Market Share by Application (2021-2026)
    2.3.5.3 Global Ultrasonic Microbubble Contrast Agents Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Ultrasonic Microbubble Contrast Agents Breakdown Data by Company
  3.1.1 Global Ultrasonic Microbubble Contrast Agents Annual Sales by Company (2021-2026)
  3.1.2 Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Company (2021-2026)
3.2 Global Ultrasonic Microbubble Contrast Agents Annual Revenue by Company (2021-2026)
  3.2.1 Global Ultrasonic Microbubble Contrast Agents Revenue by Company (2021-2026)
  3.2.2 Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Company (2021-2026)
3.3 Global Ultrasonic Microbubble Contrast Agents Sale Price by Company
3.4 Key Manufacturers Ultrasonic Microbubble Contrast Agents Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Ultrasonic Microbubble Contrast Agents Product Location Distribution
  3.4.2 Players Ultrasonic Microbubble Contrast Agents Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ULTRASONIC MICROBUBBLE CONTRAST AGENTS BY GEOGRAPHIC REGION

4.1 World Historic Ultrasonic Microbubble Contrast Agents Market Size by Geographic Region (2021-2026)
  4.1.1 Global Ultrasonic Microbubble Contrast Agents Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Ultrasonic Microbubble Contrast Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ultrasonic Microbubble Contrast Agents Market Size by Country/Region (2021-2026)
  4.2.1 Global Ultrasonic Microbubble Contrast Agents Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Ultrasonic Microbubble Contrast Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ultrasonic Microbubble Contrast Agents Sales Growth
4.4 APAC Ultrasonic Microbubble Contrast Agents Sales Growth
4.5 Europe Ultrasonic Microbubble Contrast Agents Sales Growth
4.6 Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Growth

5 AMERICAS

5.1 Americas Ultrasonic Microbubble Contrast Agents Sales by Country
  5.1.1 Americas Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  5.1.2 Americas Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026)
5.2 Americas Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026)
5.3 Americas Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Ultrasonic Microbubble Contrast Agents Sales by Region
  6.1.1 APAC Ultrasonic Microbubble Contrast Agents Sales by Region (2021-2026)
  6.1.2 APAC Ultrasonic Microbubble Contrast Agents Revenue by Region (2021-2026)
6.2 APAC Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026)
6.3 APAC Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Ultrasonic Microbubble Contrast Agents by Country
  7.1.1 Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  7.1.2 Europe Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026)
7.2 Europe Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026)
7.3 Europe Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Ultrasonic Microbubble Contrast Agents by Country
  8.1.1 Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ultrasonic Microbubble Contrast Agents
10.3 Manufacturing Process Analysis of Ultrasonic Microbubble Contrast Agents
10.4 Industry Chain Structure of Ultrasonic Microbubble Contrast Agents

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Ultrasonic Microbubble Contrast Agents Distributors
11.3 Ultrasonic Microbubble Contrast Agents Customer

12 WORLD FORECAST REVIEW FOR ULTRASONIC MICROBUBBLE CONTRAST AGENTS BY GEOGRAPHIC REGION

12.1 Global Ultrasonic Microbubble Contrast Agents Market Size Forecast by Region
  12.1.1 Global Ultrasonic Microbubble Contrast Agents Forecast by Region (2027-2032)
  12.1.2 Global Ultrasonic Microbubble Contrast Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ultrasonic Microbubble Contrast Agents Forecast by Type (2027-2032)
12.7 Global Ultrasonic Microbubble Contrast Agents Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 GE Healthcare
  13.1.1 GE Healthcare Company Information
  13.1.2 GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.1.3 GE Healthcare Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 GE Healthcare Main Business Overview
  13.1.5 GE Healthcare Latest Developments
13.2 Bracco
  13.2.1 Bracco Company Information
  13.2.2 Bracco Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.2.3 Bracco Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Bracco Main Business Overview
  13.2.5 Bracco Latest Developments
13.3 Lantheus Medical Imaging
  13.3.1 Lantheus Medical Imaging Company Information
  13.3.2 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.3.3 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Lantheus Medical Imaging Main Business Overview
  13.3.5 Lantheus Medical Imaging Latest Developments
13.4 Miltenyi Biotec
  13.4.1 Miltenyi Biotec Company Information
  13.4.2 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.4.3 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Miltenyi Biotec Main Business Overview
  13.4.5 Miltenyi Biotec Latest Developments
13.5 NanoPET Pharma
  13.5.1 NanoPET Pharma Company Information
  13.5.2 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.5.3 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 NanoPET Pharma Main Business Overview
  13.5.5 NanoPET Pharma Latest Developments
13.6 ImaRx Therapeutics
  13.6.1 ImaRx Therapeutics Company Information
  13.6.2 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.6.3 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 ImaRx Therapeutics Main Business Overview
  13.6.5 ImaRx Therapeutics Latest Developments
13.7 Microvascular Therapeutics
  13.7.1 Microvascular Therapeutics Company Information
  13.7.2 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.7.3 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Microvascular Therapeutics Main Business Overview
  13.7.5 Microvascular Therapeutics Latest Developments
13.8 POINTbiomedical
  13.8.1 POINTbiomedical Company Information
  13.8.2 POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.8.3 POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 POINTbiomedical Main Business Overview
  13.8.5 POINTbiomedical Latest Developments
13.9 Bayer
  13.9.1 Bayer Company Information
  13.9.2 Bayer Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.9.3 Bayer Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Bayer Main Business Overview
  13.9.5 Bayer Latest Developments
13.10 Qi-hui Biopharmaceutical
  13.10.1 Qi-hui Biopharmaceutical Company Information
  13.10.2 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.10.3 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Qi-hui Biopharmaceutical Main Business Overview
  13.10.5 Qi-hui Biopharmaceutical Latest Developments
13.11 Runkun Pharmaceutical
  13.11.1 Runkun Pharmaceutical Company Information
  13.11.2 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.11.3 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Runkun Pharmaceutical Main Business Overview
  13.11.5 Runkun Pharmaceutical Latest Developments
13.12 Feiruida Medical
  13.12.1 Feiruida Medical Company Information
  13.12.2 Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.12.3 Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Feiruida Medical Main Business Overview
  13.12.5 Feiruida Medical Latest Developments
13.13 Lizhuo Pharmaceutical
  13.13.1 Lizhuo Pharmaceutical Company Information
  13.13.2 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.13.3 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Lizhuo Pharmaceutical Main Business Overview
  13.13.5 Lizhuo Pharmaceutical Latest Developments
13.14 Fuman Group
  13.14.1 Fuman Group Company Information
  13.14.2 Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.14.3 Fuman Group Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Fuman Group Main Business Overview
  13.14.5 Fuman Group Latest Developments
13.15 SUN? Med-Engineering
  13.15.1 SUN? Med-Engineering Company Information
  13.15.2 SUN? Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.15.3 SUN? Med-Engineering Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 SUN? Med-Engineering Main Business Overview
  13.15.5 SUN? Med-Engineering Latest Developments
13.16 Starleaf
  13.16.1 Starleaf Company Information
  13.16.2 Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
  13.16.3 Starleaf Ultrasonic Microbubble Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Starleaf Main Business Overview
  13.16.5 Starleaf Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Ultrasonic Microbubble Contrast Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ultrasonic Microbubble Contrast Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Albumin-based Envelope
Table 4. Major Players of Liposome Envelope
Table 5. Major Players of Multimer-based Envelope
Table 6. Major Players of Others
Table 7. Global Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units)
Table 8. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2026)
Table 9. Global Ultrasonic Microbubble Contrast Agents Revenue by Type (2021-2026) & ($ million)
Table 10. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Type (2021-2026)
Table 11. Global Ultrasonic Microbubble Contrast Agents Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Ultrasonic Microbubble Contrast Agents Sale by Application (2021-2026) & (Units)
Table 13. Global Ultrasonic Microbubble Contrast Agents Sale Market Share by Application (2021-2026)
Table 14. Global Ultrasonic Microbubble Contrast Agents Revenue by Application (2021-2026) & ($ million)
Table 15. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Application (2021-2026)
Table 16. Global Ultrasonic Microbubble Contrast Agents Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Ultrasonic Microbubble Contrast Agents Sales by Company (2021-2026) & (Units)
Table 18. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Company (2021-2026)
Table 19. Global Ultrasonic Microbubble Contrast Agents Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Company (2021-2026)
Table 21. Global Ultrasonic Microbubble Contrast Agents Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Ultrasonic Microbubble Contrast Agents Producing Area Distribution and Sales Area
Table 23. Players Ultrasonic Microbubble Contrast Agents Products Offered
Table 24. Ultrasonic Microbubble Contrast Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Ultrasonic Microbubble Contrast Agents Sales by Geographic Region (2021-2026) & (Units)
Table 28. Global Ultrasonic Microbubble Contrast Agents Sales Market Share Geographic Region (2021-2026)
Table 29. Global Ultrasonic Microbubble Contrast Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Ultrasonic Microbubble Contrast Agents Sales by Country/Region (2021-2026) & (Units)
Table 32. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Country/Region (2021-2026)
Table 33. Global Ultrasonic Microbubble Contrast Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units)
Table 36. Americas Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026)
Table 37. Americas Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units)
Table 39. Americas Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units)
Table 40. APAC Ultrasonic Microbubble Contrast Agents Sales by Region (2021-2026) & (Units)
Table 41. APAC Ultrasonic Microbubble Contrast Agents Sales Market Share by Region (2021-2026)
Table 42. APAC Ultrasonic Microbubble Contrast Agents Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units)
Table 44. APAC Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units)
Table 45. Europe Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units)
Table 46. Europe Ultrasonic Microbubble Contrast Agents Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units)
Table 48. Europe Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units)
Table 49. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units)
Table 50. Middle East & Africa Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales by Type (2021-2026) & (Units)
Table 52. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales by Application (2021-2026) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Ultrasonic Microbubble Contrast Agents
Table 54. Key Market Challenges & Risks of Ultrasonic Microbubble Contrast Agents
Table 55. Key Industry Trends of Ultrasonic Microbubble Contrast Agents
Table 56. Ultrasonic Microbubble Contrast Agents Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Ultrasonic Microbubble Contrast Agents Distributors List
Table 59. Ultrasonic Microbubble Contrast Agents Customer List
Table 60. Global Ultrasonic Microbubble Contrast Agents Sales Forecast by Region (2027-2032) & (Units)
Table 61. Global Ultrasonic Microbubble Contrast Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 63. Americas Ultrasonic Microbubble Contrast Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Ultrasonic Microbubble Contrast Agents Sales Forecast by Region (2027-2032) & (Units)
Table 65. APAC Ultrasonic Microbubble Contrast Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 67. Europe Ultrasonic Microbubble Contrast Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 69. Middle East & Africa Ultrasonic Microbubble Contrast Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Ultrasonic Microbubble Contrast Agents Sales Forecast by Type (2027-2032) & (Units)
Table 71. Global Ultrasonic Microbubble Contrast Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Ultrasonic Microbubble Contrast Agents Sales Forecast by Application (2027-2032) & (Units)
Table 73. Global Ultrasonic Microbubble Contrast Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. GE Healthcare Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 75. GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 76. GE Healthcare Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. GE Healthcare Main Business
Table 78. GE Healthcare Latest Developments
Table 79. Bracco Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 80. Bracco Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 81. Bracco Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Bracco Main Business
Table 83. Bracco Latest Developments
Table 84. Lantheus Medical Imaging Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 85. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 86. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Lantheus Medical Imaging Main Business
Table 88. Lantheus Medical Imaging Latest Developments
Table 89. Miltenyi Biotec Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 90. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 91. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Miltenyi Biotec Main Business
Table 93. Miltenyi Biotec Latest Developments
Table 94. NanoPET Pharma Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 95. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 96. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. NanoPET Pharma Main Business
Table 98. NanoPET Pharma Latest Developments
Table 99. ImaRx Therapeutics Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 100. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 101. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. ImaRx Therapeutics Main Business
Table 103. ImaRx Therapeutics Latest Developments
Table 104. Microvascular Therapeutics Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 105. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 106. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Microvascular Therapeutics Main Business
Table 108. Microvascular Therapeutics Latest Developments
Table 109. POINTbiomedical Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 110. POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 111. POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. POINTbiomedical Main Business
Table 113. POINTbiomedical Latest Developments
Table 114. Bayer Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 115. Bayer Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 116. Bayer Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Bayer Main Business
Table 118. Bayer Latest Developments
Table 119. Qi-hui Biopharmaceutical Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 120. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 121. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Qi-hui Biopharmaceutical Main Business
Table 123. Qi-hui Biopharmaceutical Latest Developments
Table 124. Runkun Pharmaceutical Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 125. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 126. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Runkun Pharmaceutical Main Business
Table 128. Runkun Pharmaceutical Latest Developments
Table 129. Feiruida Medical Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 130. Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 131. Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Feiruida Medical Main Business
Table 133. Feiruida Medical Latest Developments
Table 134. Lizhuo Pharmaceutical Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 135. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 136. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Lizhuo Pharmaceutical Main Business
Table 138. Lizhuo Pharmaceutical Latest Developments
Table 139. Fuman Group Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 140. Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 141. Fuman Group Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Fuman Group Main Business
Table 143. Fuman Group Latest Developments
Table 144. SUN? Med-Engineering Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 145. SUN? Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 146. SUN? Med-Engineering Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. SUN? Med-Engineering Main Business
Table 148. SUN? Med-Engineering Latest Developments
Table 149. Starleaf Basic Information, Ultrasonic Microbubble Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 150. Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolios and Specifications
Table 151. Starleaf Ultrasonic Microbubble Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Starleaf Main Business
Table 153. Starleaf Latest Developments

LIST OF FIGURES

Figure 1. Picture of Ultrasonic Microbubble Contrast Agents
Figure 2. Ultrasonic Microbubble Contrast Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ultrasonic Microbubble Contrast Agents Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Ultrasonic Microbubble Contrast Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ultrasonic Microbubble Contrast Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ultrasonic Microbubble Contrast Agents Sales Market Share by Country/Region (2025)
Figure 10. Ultrasonic Microbubble Contrast Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Albumin-based Envelope
Figure 12. Product Picture of Liposome Envelope
Figure 13. Product Picture of Multimer-based Envelope
Figure 14. Product Picture of Others
Figure 15. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Type in 2026
Figure 16. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Type (2021-2026)
Figure 17. Ultrasonic Microbubble Contrast Agents Consumed in Liver Ultrasonography
Figure 18. Global Ultrasonic Microbubble Contrast Agents Market: Liver Ultrasonography (2021-2026) & (Units)
Figure 19. Ultrasonic Microbubble Contrast Agents Consumed in Angiographic Ultrasonography
Figure 20. Global Ultrasonic Microbubble Contrast Agents Market: Angiographic Ultrasonography (2021-2026) & (Units)
Figure 21. Ultrasonic Microbubble Contrast Agents Consumed in Cardiac Ultrasonography
Figure 22. Global Ultrasonic Microbubble Contrast Agents Market: Cardiac Ultrasonography (2021-2026) & (Units)
Figure 23. Ultrasonic Microbubble Contrast Agents Consumed in Others
Figure 24. Global Ultrasonic Microbubble Contrast Agents Market: Others (2021-2026) & (Units)
Figure 25. Global Ultrasonic Microbubble Contrast Agents Sale Market Share by Application (2025)
Figure 26. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Application in 2026
Figure 27. Ultrasonic Microbubble Contrast Agents Sales by Company in 2026 (Units)
Figure 28. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Company in 2026
Figure 29. Ultrasonic Microbubble Contrast Agents Revenue by Company in 2026 ($ millions)
Figure 30. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Company in 2026
Figure 31. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Ultrasonic Microbubble Contrast Agents Sales 2021-2026 (Units)
Figure 34. Americas Ultrasonic Microbubble Contrast Agents Revenue 2021-2026 ($ millions)
Figure 35. APAC Ultrasonic Microbubble Contrast Agents Sales 2021-2026 (Units)
Figure 36. APAC Ultrasonic Microbubble Contrast Agents Revenue 2021-2026 ($ millions)
Figure 37. Europe Ultrasonic Microbubble Contrast Agents Sales 2021-2026 (Units)
Figure 38. Europe Ultrasonic Microbubble Contrast Agents Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales 2021-2026 (Units)
Figure 40. Middle East & Africa Ultrasonic Microbubble Contrast Agents Revenue 2021-2026 ($ millions)
Figure 41. Americas Ultrasonic Microbubble Contrast Agents Sales Market Share by Country in 2026
Figure 42. Americas Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2026)
Figure 43. Americas Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2026)
Figure 44. Americas Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2021-2026)
Figure 45. United States Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Ultrasonic Microbubble Contrast Agents Sales Market Share by Region in 2026
Figure 50. APAC Ultrasonic Microbubble Contrast Agents Revenue Market Share by Region (2021-2026)
Figure 51. APAC Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2026)
Figure 52. APAC Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2021-2026)
Figure 53. China Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. India Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share by Country in 2026
Figure 61. Europe Ultrasonic Microbubble Contrast Agents Revenue Market Share by Country (2021-2026)
Figure 62. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2026)
Figure 63. Europe Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2021-2026)
Figure 64. Germany Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. France Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Market Share by Application (2021-2026)
Figure 72. Egypt Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Ultrasonic Microbubble Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Ultrasonic Microbubble Contrast Agents in 2026
Figure 78. Manufacturing Process Analysis of Ultrasonic Microbubble Contrast Agents
Figure 79. Industry Chain Structure of Ultrasonic Microbubble Contrast Agents
Figure 80. Channels of Distribution
Figure 81. Global Ultrasonic Microbubble Contrast Agents Sales Market Forecast by Region (2027-2032)
Figure 82. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Ultrasonic Microbubble Contrast Agents Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Ultrasonic Microbubble Contrast Agents Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Ultrasonic Microbubble Contrast Agents Revenue Market Share Forecast by Application (2027-2032)


More Publications